|Net Assets||8.43 Bil|
|Morningstar Risk||Above Average|
- Last NAV update 12/10/2013 4:00 PM ET
|The investment seeks long-term capital appreciation. The fund normally invests at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While it can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies. The fund may invest in foreign stocks and options in keeping with the fund's objectives.|
- Year to date performance as of 12/10/2013 12:00 AM ET
|Fund Family||T. Rowe Price|
|Fund Manager||Taymour Tamaddon|
|Minimum Initial Purchase||2,500.00|
|Minimum IRA Investment||1,000.00|
- * Annualized returns
- Performance as of 12/10/2013 12:00 AM ET
|Net Assets||8.43 Bil||693.18 Mil|
|Avg Market Cap||11.97 Bil||24.01 Bil|
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.